Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

The detection of actionable mutations in liquid biopsies is a crucial tool for precision oncology in patients with non‐small‐cell lung cancer (NSCLC). We evaluated actionable alterations using a multigene panel in circulating tumor DNA (ctDNA) from Brazilian NSCLC patients. We analyzed 32 samples fr...

Полное описание

Библиографические подробности

Главные авторы:	Giovanna Maria Stanfoca Casagrande, Marcela deOliveira Silva, Mariana Bisarro dosReis, Rodrigo deOliveira Cavagna, Luciane Sussuchi, Icaro Alves Pinto, Natalia Zampieri Pontes, Rodrigo Sampaio Chiarantano, Flavio Augusto Ferreira daSilva, Pedro deMarchi, Letícia Ferro Leal, Rui M. Reis
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Wiley 2026-03-01
Серии:	Molecular Oncology
Предметы:	actionable mutations ctDNA liquid biopsy lung cancer
Online-ссылка:	https://doi.org/10.1002/1878-0261.70131
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!